Cargando…
Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression
Limited clinical benefit has been demonstrated for chimeric antigen receptor (CAR) therapy of solid tumors, but coengineering strategies to generate so-called fourth-generation (4G) CAR-T cells are advancing toward overcoming barriers in the tumor microenvironment (TME) for improved responses. In la...
Autores principales: | Lanitis, Evripidis, Rota, Giorgia, Kosti, Paris, Ronet, Catherine, Spill, Aodrenn, Seijo, Bili, Romero, Pedro, Dangaj, Denarda, Coukos, George, Irving, Melita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653685/ https://www.ncbi.nlm.nih.gov/pubmed/33156338 http://dx.doi.org/10.1084/jem.20192203 |
Ejemplares similares
-
VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding
por: Lanitis, Evripidis, et al.
Publicado: (2021) -
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8(+) T cells
por: Corria-Osorio, Jesus, et al.
Publicado: (2023) -
Targeting the tumor vasculature to enhance T cell activity
por: Lanitis, Evripidis, et al.
Publicado: (2015) -
Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels
por: Lanitis, Evripidis, et al.
Publicado: (2012) -
Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival
por: Karapetsas, Athanasios, et al.
Publicado: (2015)